相关实验视频

Updated: Jun 28, 2025

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

在海湾合作委员会 (GCC) 国家的X结合性低酸性狂风病的经验:案例系列

Fahad Al-Juraibah^1,2, Adnan Al Shaikh^1,3, Afaf Al-Sagheir⁴

¹College of Medicine, King Saud bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia.

Endocrinology, diabetes & metabolism case reports

|April 13, 2024

概括

用布罗苏马布治疗X相关的低血性狂风病 (XLH) 显示,生物化学标志物和患者的生活质量有显著改善. 传统疗法在很大程度上是无效的,并与不良影响相关,突出布罗苏马布.

科学领域:

遗传学和分子生物学
儿科内分泌学儿科内分泌学
罕见疾病罕见疾病

背景情况:

链接到X的低血性狂犬病 (XLH) 是一种普遍的遗传性疾病,由PHEX基因突变引起.
对于XLH的传统疗法通常会产生不理想的临床和生化结果.
传统治疗的不良影响可能会损害患者的生活质量和治疗坚持.

研究的目的:

评估来自海湾合作委员会国家的XLH患者的布洛苏马布的疗效和安全性.
为了比较传统疗法和布罗苏马布之间的治疗反应.
评估布罗苏马布对XLH患者生化标志物,临床症状和生活质量的影响.

主要方法:

来自海湾合作委员会国家的14名XLH患者 (年龄在2-40岁) 的病例系列.
医学史,生化和放射学发现的审查.
对传统疗法和布罗苏马布治疗反应和副作用的分析.

主要成果:

传统疗法对病症状和生化参数的改善或恶化程度有限.
布罗苏马布治疗导致血清酸盐和TmP/GFR比率显著改善.
布罗苏马布还改善了血清ALP和PTH水平,减少了疼痛,虚弱和疲劳,没有显著的副作用.

结论:

布罗苏马布为XLH提供了一个有前途的治疗选择,显示出明显的生物化学和临床改善.
对XLH的常规疗法与显著的副作用和有限的疗效有关.
布罗苏马布治疗改善了XLH患者的生活质量和治疗坚持.

更多相关视频

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

相关概念视频

Sex-linked Disorders

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...